Matches in SemOpenAlex for { <https://semopenalex.org/work/W2762737041> ?p ?o ?g. }
- W2762737041 endingPage "301" @default.
- W2762737041 startingPage "291" @default.
- W2762737041 abstract "The variable disease course of autosomal dominant polycystic kidney disease (ADPKD) makes it important to develop biomarkers that can predict disease progression, from a patient perspective and to select patients for renoprotective treatment. We therefore investigated whether easy-to-measure urinary biomarkers are associated with disease progression and have additional value over that of conventional risk markers.At baseline, inflammatory, glomerular, and tubular damage markers were measured in 24-hour urine collections (albumin, IgG, kidney injury molecule-1 (KIM-1), N-acetyl-β-d-glucosaminidase (NAG), β2 microglobulin (β2MG), heart-type fatty acid binding protein (HFABP), macrophage migration inhibitory factor (MIF), neutrophil gelatinase-associated lipocalin (NGAL), and monocyte chemotactic protein-1 (MCP-1). Disease progression was expressed as annual change in estimated glomerular filtration rate (eGFR, Chronic Kidney Disease EPIdemiology equation), measured glomerular filtation rate (mGFR, using 125I-iothalamate), or height-adjusted total kidney volume (htTKV). Multivariable linear regression was used to assess associations of these markers independent of conventional risk markers.A total of 104 ADPKD patients were included (40 ± 11 years, 39% female, eGFR 77 ± 30, mGFR 79 ± 30 ml/min per 1.73 m2 and htTKV 852 [510-1244] ml/m). In particular, β2MG and MCP-1 were associated with annual change in eGFR, and remained associated after adjustment for conventional risk markers (standardized β = -0.35, P = 0.001, and standardized β = -0.29, P = 0.009, respectively). Adding β2MG and MCP-1 to a model containing conventional risk markers that explained annual change in eGFR significantly increased the performance of the model (final R2 = 0.152 vs. 0.292, P = 0.001). Essentially similar results were obtained when only patients with an eGFR ≥ 60 ml/min per 1.73 m2 were selected, or when change in mGFR was studied. Associations with change in htTKV were less strong.Urinary β2MG and MCP-1 excretion were both associated with GFR decline in ADPKD, and had added value beyond that of conventional risk markers. These markers therefore have the potential to serve as predictive tools for clinical practice." @default.
- W2762737041 created "2017-10-20" @default.
- W2762737041 creator A5005549802 @default.
- W2762737041 creator A5008623288 @default.
- W2762737041 creator A5011298606 @default.
- W2762737041 creator A5013594343 @default.
- W2762737041 creator A5013947762 @default.
- W2762737041 creator A5019478492 @default.
- W2762737041 creator A5020587186 @default.
- W2762737041 creator A5025396478 @default.
- W2762737041 creator A5045844188 @default.
- W2762737041 creator A5077662262 @default.
- W2762737041 date "2018-03-01" @default.
- W2762737041 modified "2023-10-05" @default.
- W2762737041 title "Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression" @default.
- W2762737041 cites W1554013484 @default.
- W2762737041 cites W1817103647 @default.
- W2762737041 cites W1963496085 @default.
- W2762737041 cites W1963623990 @default.
- W2762737041 cites W1971422595 @default.
- W2762737041 cites W1987464952 @default.
- W2762737041 cites W1990748367 @default.
- W2762737041 cites W1991937960 @default.
- W2762737041 cites W1997286719 @default.
- W2762737041 cites W2000265546 @default.
- W2762737041 cites W2000432883 @default.
- W2762737041 cites W2002366936 @default.
- W2762737041 cites W2010668846 @default.
- W2762737041 cites W2014786231 @default.
- W2762737041 cites W2038382302 @default.
- W2762737041 cites W2048280250 @default.
- W2762737041 cites W2055919784 @default.
- W2762737041 cites W2069276061 @default.
- W2762737041 cites W2079855152 @default.
- W2762737041 cites W2085576811 @default.
- W2762737041 cites W2085839558 @default.
- W2762737041 cites W2101067234 @default.
- W2762737041 cites W2102078026 @default.
- W2762737041 cites W2107304903 @default.
- W2762737041 cites W2112643254 @default.
- W2762737041 cites W2116444145 @default.
- W2762737041 cites W2122144371 @default.
- W2762737041 cites W2129925362 @default.
- W2762737041 cites W2130657993 @default.
- W2762737041 cites W2131166928 @default.
- W2762737041 cites W2134935161 @default.
- W2762737041 cites W2151157805 @default.
- W2762737041 cites W2155965977 @default.
- W2762737041 cites W2163673475 @default.
- W2762737041 cites W2172223249 @default.
- W2762737041 cites W2269899460 @default.
- W2762737041 cites W2318270239 @default.
- W2762737041 cites W2572405581 @default.
- W2762737041 cites W2586813559 @default.
- W2762737041 cites W2605806871 @default.
- W2762737041 cites W2607031541 @default.
- W2762737041 cites W2735224645 @default.
- W2762737041 cites W2744855293 @default.
- W2762737041 doi "https://doi.org/10.1016/j.ekir.2017.10.004" @default.
- W2762737041 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5932128" @default.
- W2762737041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29725632" @default.
- W2762737041 hasPublicationYear "2018" @default.
- W2762737041 type Work @default.
- W2762737041 sameAs 2762737041 @default.
- W2762737041 citedByCount "24" @default.
- W2762737041 countsByYear W27627370412018 @default.
- W2762737041 countsByYear W27627370412019 @default.
- W2762737041 countsByYear W27627370412020 @default.
- W2762737041 countsByYear W27627370412021 @default.
- W2762737041 countsByYear W27627370412022 @default.
- W2762737041 countsByYear W27627370412023 @default.
- W2762737041 crossrefType "journal-article" @default.
- W2762737041 hasAuthorship W2762737041A5005549802 @default.
- W2762737041 hasAuthorship W2762737041A5008623288 @default.
- W2762737041 hasAuthorship W2762737041A5011298606 @default.
- W2762737041 hasAuthorship W2762737041A5013594343 @default.
- W2762737041 hasAuthorship W2762737041A5013947762 @default.
- W2762737041 hasAuthorship W2762737041A5019478492 @default.
- W2762737041 hasAuthorship W2762737041A5020587186 @default.
- W2762737041 hasAuthorship W2762737041A5025396478 @default.
- W2762737041 hasAuthorship W2762737041A5045844188 @default.
- W2762737041 hasAuthorship W2762737041A5077662262 @default.
- W2762737041 hasBestOaLocation W27627370411 @default.
- W2762737041 hasConcept C126322002 @default.
- W2762737041 hasConcept C126894567 @default.
- W2762737041 hasConcept C134018914 @default.
- W2762737041 hasConcept C136935669 @default.
- W2762737041 hasConcept C159641895 @default.
- W2762737041 hasConcept C20299238 @default.
- W2762737041 hasConcept C2776266639 @default.
- W2762737041 hasConcept C2778653478 @default.
- W2762737041 hasConcept C2779134260 @default.
- W2762737041 hasConcept C2780145431 @default.
- W2762737041 hasConcept C2780306776 @default.
- W2762737041 hasConcept C2781197716 @default.
- W2762737041 hasConcept C55493867 @default.
- W2762737041 hasConcept C71924100 @default.
- W2762737041 hasConcept C86803240 @default.